Plastomics was founded on the premise that crop biotechnology had been looking in the wrong place. For four decades, agricultural biotech focused almost exclusively on the plant nucleus — the most obvious site to insert a new gene. But some of the most important genes in agriculture aren't in the nucleus. They're in the chloroplast.
The chloroplast genome encodes the machinery of photosynthesis — the single most important biological process in agriculture. Improving it could unlock step-change gains in crop yield, protein production, and resilience. But doing so requires the ability to access, transform, and edit chloroplast genes. That's what Plastomics was built to do.
To unlock the full potential of the chloroplast — engineering crops that are more productive, more resilient, and more capable than what's possible through nuclear biotech alone.
Based in St. Louis, Missouri — the world's center of agricultural innovation. We bring together plant molecular biologists, crop scientists, and regulatory experts united by a single mission. St. Louis has long been home to the science that feeds the world; Plastomics is proud to carry that tradition into the next frontier of crop engineering.
The people behind the platform
Co-founder. PhD in Microbiology & Molecular Genetics, with 20+ years of technology leadership.
30+ years of commercial, M&A, and financial leadership. Ag industry advisor.
PhD in Plant Breeding & Genetics, with 15+ years in crop transformation, genome editing, and production leadership.
Build on the only chloroplast platform in agriculture.
Plastomics works with seed companies, biotech and pharma organizations, and academic institutions. Whatever your crop, trait, or timeline, there is a partnership model that works.
The next frontier beyond nuclear germplasm
- ▸Add traits with dramatically higher expression than your current nuclear pipeline
- ▸Eliminate pollen containment concerns for biotech crops
- ▸Access regulatory-friendly gene editing with no foreign DNA
- ▸Stack multiple traits in a single transformation event
A contained, high-output platform for complex molecules
- ▸Develop plant-made pharmaceuticals with built-in maternal containment
- ▸Access photosynthesis gene engineering for yield programs
- ▸License chloroplast transformation for your crop portfolio
Advance the frontier of chloroplast science
- ▸Co-develop chloroplast engineering tools for new species and applications
- ▸Publish joint research on chloroplast editing and photosynthesis
- ▸Access our platform in exchange for IP co-development
The latest from Plastomics
Press releases, publications, and milestones will appear here as they are released.
Subscribe to updates →